Xtresse

What Xtresse does

Xtressé (legally Restore Biologics Holdings, LLC) is a dermatologist-founded hair restoration company that launched in February 2025 with a three-tier "stress-adaptive" hair therapy system targeting the more than 80 million Americans experiencing hair thinning or loss. The portfolio includes Hair Growth Gummies (a biotin-free, sugar-free daily supplement featuring the proprietary X3-BioActive Blend with NAD+, taurine, saw palmetto, pumpkin seed extract, and other micronutrients), FR Concentrate Serum (a topical oligopeptide blend featuring the patent-pending X3-Peptide Complex with GHK-Cu, BPC-157, and Zinc Thymulin), and the in-office Xvie XO Concentrate, a regenerative treatment derived from amniotic fluid containing 700+ unique growth factors. The Xtressé Grow System ($387) bundles the gummies and serum for a comprehensive at-home protocol, while Xvie is positioned as a clinical-stage extracellular vesicle therapy now in Phase I/II trials.

The company operates a dual-channel go-to-market: direct-to-consumer via xtresse.com with a subscription model (20% savings, free shipping, 30/90/180-day delivery cadence) plus one-time purchases, and a professional/B2B channel through an authorized provider network of dermatology practices and medical spas (Xvie available exclusively through authorized providers). Disclosed clinical evidence includes a pilot study showing 23% relative improvement in global hair thinning over 4 months in women with female pattern hair loss, a peer-reviewed result that 90% of patients saw visible improvement with daily gummy use, and 81.8% of subjects showing increased hair counts with +6.78 additional terminal hairs per cm². In March 2026 the FDA accepted the Investigational New Drug (IND) application for Xvie, making it the first and only extracellular vesicle injectable therapy to enter clinical trials for androgenetic alopecia.

The Orlando, Florida-based company operates with 1–10 employees, has raised $2.69M in a single funding round in November 2025, and has received multiple industry awards including the 2025 NutraIngredients Product of the Year (Beauty-From-Within), the 2025 NewBeauty 100 What's Next In Beauty, and the 2026 NewBeauty Best Hair Growth Supplement. Leadership is anchored by Co-Founder Matt Leavitt, DO (a globally recognized hair restoration specialist with 75,000+ hair transplants and 50+ clinical trials) and CSO Trillitye Paullin, PhD, alongside five additional board-certified dermatologists as founding members, providing clinical credibility that anchors both the consumer brand and the professional channel.

Name

Xtresse

Legal name

Restore Biologics Holdings, LLC

Website

https://xtresse.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Xtressé is a dermatologist-founded hair restoration company offering a three-tier system: biotin-free Hair Growth Gummies, FR Concentrate Serum, and clinical-stage Xvie extracellular vesicle therapy. It sells direct-to-consumer via xtresse.com subscriptions and through an authorized provider network of dermatologists.

Ownership category

akta.pro rank

Product category

Hair Growth Nutraceuticals and Topical Hair Restoration

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Treatments & Scalp Care (Serums, Oils, Anti-dandruff, Growth) (CRABABAE)

akta.pro secondary industries

Professional Hair Care (Shampoo, Conditioner, Treatments) (CRABALAB), Hair Treatments & Scalp Care (Keratin/Botox/Deep Conditioning) (HSALAAAF)

Keywords

• Hair growth supplements
• Dermatologist hair care
• Regenerative hair therapy
• Peptide hair serum
• Nutraceutical hair restoration

Headquarters

HQ city

Orlando

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Consumer Subscription: Recurring subscription revenue from direct-to-consumer sales of Hair Growth Gummies and FR Concentrate Serum. Subscribers receive 20% discount and free shipping. Delivery options every 30, 90, or 180 days.
2. One-Time Product Sales: Non-subscription purchases of Hair Growth Gummies, FR Concentrate Serum, and Xtressé Grow System at standard retail pricing with $5 flat-rate shipping.
3. Professional/Wholesale: B2B sales to dermatology practices, medical spas, and hair restoration clinics through professional program with wholesale pricing, marketing materials, and clinical education resources.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Xtressé develops and sells a three-tier dermatologist-developed hair restoration system: daily Hair Growth Gummies with its proprietary X3-BioActive Blend, topical FR Concentrate Serum with the patent-pending X3-Peptide Complex, and the Xtressé Grow System bundle. The company also supplies the Xvie XO Concentrate (in-office regenerative treatment with 700+ growth factors) and is advancing Xvie, an FDA IND-accepted extracellular vesicle injectable therapy, for androgenetic alopecia. Products are sold direct-to-consumer via xtresse.com on a subscription model and through an Authorized Provider Network of dermatology practices and medical spas.

Product overview

Xtressé is a dermatologist-founded hair and scalp therapy company offering a multi-level stress-adaptive hair growth system. The core product portfolio consists of Hair Growth Gummies (biotin-free daily supplement with NAD+ and proprietary X3-BioActive Blend), FR Concentrate Serum (topical oligopeptide blend for follicle repair), and the Xtressé Grow System (combination of both). Xvie XO Concentrate is an advanced in-office professional treatment with 700+ growth factors available through authorized providers. Xvie is an injectable extracellular vesicle therapy in clinical development for androgenetic alopecia. The three-level system progresses from Nourish (gummies) to Repair (serum) to Reactivate (Xvie professional treatments), targeting early thinning through advanced hair loss.

Differentiator

Problem solved

Functional benefit

Products and services

• Hair Growth Gummies Biotin-free, sugar-free, drug-free daily gummy supplement powered by proprietary X3 Technologies and X3-BioActive Blend, containing NAD+, pumpkin seed extract, taurine, and saw palmetto to support hair growth from within. Sold to adult consumers on a subscribe-and-save or one-time basis.
• FR Concentrate Serum Topical oligopeptide blend formulated for follicle repair using the X3-Peptide Complex, GHK-Cu (Copper Peptide), BPC-157, and Zinc Thymulin to target repair at the root and support follicle health. Used by adult consumers as part of a hair growth routine.
• Xtressé Grow System Dual-action system pairing Hair Growth Gummies with FR Concentrate Serum for comprehensive hair health support from within and at the root, clinically supported to show visible results in as little as 3 months. Sold as a $387.00 one-time kit to adult consumers.
• Xvie XO Concentrate Advanced in-office professional treatment containing 700+ unique growth factors and peptides derived from amniotic fluid, designed to reactivate the follicle microenvironment. Available exclusively through authorized dermatology and hair restoration providers for in-office administration to patients with advanced hair loss.
• Xvie Extracellular vesicle injectable therapy derived from amniotic fluid containing over 700 growth factors and proteins. Targets the underlying biology of androgenetic alopecia through a multi-signal approach. First and only EV injectable therapy to receive FDA IND acceptance for androgenetic alopecia, now entering Phase I/II clinical trials.

Quantifiable outcome

• 90% of patients showed visible improvement within 4 months of daily use
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Dermatology Practices and Medical SpascoreChannel Partner/ Reseller/ DistributorXtressé partners with dermatology practices, medical spas, and hair restoration clinics to offer professional products and Xvie treatments. Partners receive wholesale pricing, marketing materials, clinical education, and training. Xvie treatments available exclusively through authorized providers.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Keeps: Keeps is a DTC subscription brand focused exclusively on hair loss treatments for men, offering finasteride and minoxidil. Direct competitor in the subscription hair loss treatment category targeting similar consumer demographics.
• Viviscal: Viviscal is a hair growth supplement brand featuring marine complex AminoMar, sold through retail and DTC channels. Direct competitor in the hair growth nutraceutical category with longer market history and broader retail distribution.
• Nutrafol: Nutrafol is the leading DTC hair growth supplement brand, offering physician-formulated nutraceuticals for hair thinning. Direct competitor in the clinical-grade hair growth gummy/capsule category with similar dermatologist positioning and subscription model.
• Hims & Hers Health: Hims & Hers offers DTC hair loss treatments including topical minoxidil, finasteride prescriptions, and supplements. Direct competitor in the consumer hair loss category with much larger scale, telehealth infrastructure, and pharmacy partnerships.

Emerging players

• Vegamour: Vegamour offers plant-based hair growth serums and supplements targeting the clean beauty segment. Emerging competitor with similar DTC subscription model and focus on natural/botanical ingredients, though without clinical-stage biologic assets.
• Follixin: Follixin is a hair growth supplement brand sold primarily through online channels targeting similar consumer demographics. Emerging competitor in the hair growth nutraceutical category with comparable pricing structure.
• Stemson Therapeutics: Stemson Therapeutics is a regenerative medicine company developing iPSC-derived cell therapies for hair loss. Emerging competitor in the clinical-stage regenerative hair restoration space pursuing a different technical approach than Xtressé's EV-based Xvie.

Broad incumbents

• Bosley: Bosley is the largest US hair restoration clinic network offering surgical transplants and physician-supervised treatments. Established incumbent in the professional hair restoration space with which Xtressé's Xvie injectable competes for medical provider partnerships.
• Propecia/finasteride generics: Propecia (finasteride) is the leading oral prescription for male pattern hair loss, now widely available as low-cost generics. Established Rx incumbent that any new hair loss entrant must compete against in efficacy and convenience.
• Rogaine (Johnson & Johnson): Rogaine is the OTC minoxidil market leader with decades of brand recognition and pharmacy distribution. Established incumbent that defines the baseline treatment against which all newer entrants like Xtressé must differentiate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/xtressehairtherapy
• TikToktiktok.com/@xtressehairtherapy
• Xx.com/xtresse_

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xtresse